Cargando…
Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells
The antigenic makeup of tumour cells can have a profound effect on the progression of cancer and success of immunotherapies. Therefore, one strategy to improve the efficacy of cancer treatments is to augment the antigens displayed by tumours. The present study explores how the recognition of tumour...
Autores principales: | Gravett, A. M., Trautwein, N., Stevanović, S., Dalgleish, A. G., Copier, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990974/ https://www.ncbi.nlm.nih.gov/pubmed/29930882 http://dx.doi.org/10.1080/2162402X.2018.1438107 |
Ejemplares similares
-
In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells
por: Gravett, Andrew M., et al.
Publicado: (2019) -
The immunopeptidomic landscape of ovarian carcinomas
por: Schuster, Heiko, et al.
Publicado: (2017) -
Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells
por: Smith, P. L., et al.
Publicado: (2020) -
The Impact of Biomaterial Cell Contact on the Immunopeptidome
por: Ghosh, Michael, et al.
Publicado: (2020) -
The efficacy of chemotherapeutic drug combinations may be predicted by concordance of gene response to the single agents
por: Gravett, Andrew M., et al.
Publicado: (2020)